Neurol. praxi. 2009;10(5):294-296

The significance of cerebrospinal fluid cytology for diagnosing tumors of the nervous system

doc. MUDr. Pavel Štourač, Ph.D1, MUDr. Jana Bednářová, Ph.D2, MUDr. Zdeňka Čermáková2
1 Neurologická klinika LF MU a FN u sv. Anny, Brno
2 Biochemické oddělení Fakultní nemocnice Brno

Qualitative cerebrospinal fluid cytology is an essential examination in all patients who have suspected or confirmed tumorous disease

and in samples with pleocytosis and hyperproteinorachia to rule out or confirm the presence of cancer cells. Tumor infiltration proved

by cerebrospinal fluid cytology remains important even in the era of imaging techniques and may significantly contribute to early

diagnosis and treatment of tumor infiltration in both primary and metastatic tumors of the nervous system. Despite the well-known

incidence rates of the individual tumor types, we detected rare tumors in our cohort that cause leptomeningeal infiltration: urinary tract

carcinoma, choriod plexus papiloma, and retinoblastoma.

Keywords: quantitative and qualitative cerebrospinal fluid cytology, primary and secondary NS tumors, total protein in CSF.

Published: December 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Štourač P, Bednářová J, Čermáková Z. The significance of cerebrospinal fluid cytology for diagnosing tumors of the nervous system. Neurol. praxi. 2009;10(5):294-296.
Download citation

References

  1. Adam P, Taborsky L, Prucha M, Sobek O, Kratochvil J, Zeman D. Cerebrospinal Fluid Cytology. A Monograph, Medica News Publisher, Prague 2000.
  2. Kluge H. Atlas of CSF Cytology, GeorgThieme Verlag, 2007. Go to original source...
  3. Recht L, Mrugala M. Neurologic complications of hematologic neoplasma Neurol Clin N Am 2003; 21: 87-105. Go to original source... Go to PubMed...
  4. MacKenzie JM. Malignant meningitis: a rational approach to cerebrospinal fluid cytology J Clin Pathol 1996; 49: 497-499. Go to original source... Go to PubMed...
  5. Hayward RA, Shapiro MF, Oye RK. Laboratory testing on cerebrospinal fluid. A reappraisal Lancet 1987; i: 1-4. Go to original source... Go to PubMed...
  6. Thomas LB. Pathology of leukemia in the brain and meninges: postmortem studies of patients with acute leukemias and of mice given inoculations of L1210 leukemia. Cancer Res 1965; 25: 1555-1571.
  7. Bleyer WA. Central nervous system leukemia. Pediatr Clin North Am 1988; 35: 789-814. Go to original source... Go to PubMed...
  8. Posner JB. Neurologic Complications of Cancer, Davis FA Company, Philadelphia 1995.
  9. Jayson GC, Howell A, Hartus M, Morgenstern G, Chang J, Ryder WD. Carcinomatous meningitis in patiens with breast cancer - an aggressive disease variant. Cancer 1978; 74: 3135-3141. Go to original source...
  10. Lee JL, Kang YK, Kim TW, Chang HM, LeeGW, Ryu MH, Kim E, Oh SJ, Lee JH, Kim SB, Kim SW, Suh C, Lee JS, Kim WK, Kim SH. Leptomeningeal carcinomatosis in gastric cancer. J Neurol-Oncol 2004; 66: 167-174. Go to original source... Go to PubMed...
  11. Smith DB, Howell A, Harris M, Bramwell VHC, Sellwood RA. Carcinomatous meningitis associated with infiltrating lobular carcinoma of the breast Eur J Surg Oncol 1985; 11: 33-36.
  12. Zeltzer PM, Boyett JM, Inlay JL, Albright AL, Rorke LB, Milstein JM, Allen JC, Stevens KR, Stanley P, Hao Li, Wisoff JH, Geyer JR, McGuire-Cullen P, Stehbens JA, Shurin SB, Packer RJ. Metastasis stage, adjuvant treatment and residual tumor are prognostic factors for medulloblastoma in children. J Clin Oncol 1999; 17: 832-845. Go to original source... Go to PubMed...
  13. Fouladi M, Gajjar A, Boyett JM, Walter AW, Thompson SJ, Merchant TE, Jenkins JJ, Langston JW, Liu A, Kun LE, Heideman RL. Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor. J Clin Oncol 1999; 17: 3234-3237. Go to original source... Go to PubMed...
  14. DeAngelis LM. Current diagnosis and treatment of leptomeningeal metastasis J Neurol Oncol 1999; 38: 245-252. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.